HD-OPM Archive
Topics › Heart attack, stroke & procedures

First placebo-controlled CTO PCI trial: less chest pain, better quality of life

Louis Nervegna · Mar 29, 2026 · ♥ 1 reactions · 1 comments · original Facebook post
Heart attack, stroke & procedures
AI summary & key facts

JACC Journals reports what is believed to be the first randomized placebo-controlled trial of reopening a chronic total coronary occlusion by PCI. Patients receiving the procedure had statistically significant reductions in chest pain and better quality of life than those given a placebo procedure; presented at ACC.26.

(no text — see the shared post below)

Research cited

In what is believed to be the first randomized placebo-controlled trial of its kind, patients with a chronic total blockage of a coronary artery who received a nonsurgical procedure to reopen the artery showed statistically significant reductions in chest pain and improvements in quality of life compared with patients who received a placebo procedure. The research was presented at #ACC26.

Get the details in #JACC: Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary… (JACC, 2026) #PCI #CTO

No photo description available.
← newer: PREDIMED: free nuts roughly halved stroke risk, and walnuts older: Stuart Phillips: the 1.6 g/kg protein ceiling holds for olde →